Sildalis is a combination medication designed to treat erectile dysfunction by enhancing sexual performance. It is used to help men achieve and maintain an erection sufficient for satisfactory sexual activity. The drug contains two active ingredients that work together to increase blood flow to the penis. During sexual stimulation the medication promotes relaxation of smooth muscle in the penile arteries and corpus cavernosum. The first component acts as a phosphodiesterase type five inhibitor preventing the breakdown of cyclic guanosine monophosphate that mediates smooth muscle relaxation. The second component provides mild vasodilatory support further facilitating arterial inflow during arousal. Together these actions lead to engorgement of the erectile tissue producing a firm and sustained erection. Thus Sildalis functions by pharmacologically enhancing the natural erectile response through targeted vascular effects.

Sildalis is a combination pharmaceutical medication containing tadalafil and dapagliflozin. It is prescribed for the treatment of erectile dysfunction and type 2 diabetes mellitus. Tadalafil functions as a phosphodiesterase type 5 inhibitor, increasing blood flow to the penis during sexual stimulation. Dapagliflozin operates as a sodium-glucose cotransporter 2 inhibitor, promoting the excretion of excess glucose through urine. The combined action of these components addresses both vascular insufficiency related to erectile dysfunction and glycemic control in diabetes management. This dual mechanism targets specific biological pathways to enhance physiological responses in the intended patient populations. The medication achieves its therapeutic effects by modulating cardiovascular and metabolic processes through these targeted interactions.

Common reactions of Sildalis often involve mild headache. Some users experience temporary facial flushing. Occasional gastrointestinal disturbances such as loose stools have been reported. Sleep disturbances including difficulty staying asleep are occasionally observed. Vision changes such as blurred sight or increased sensitivity to light may occur. Most reactions are short lived and resolve without medical intervention.

Common side effects of Sildalis can include headache fatigue dizziness flushing nasal congestion and mild stomach upset. These symptoms are generally transient and diminish with continued use. Some users may experience a temporary reduction in blood pressure leading to lightheadedness upon standing. Vision changes such as blurred sight or heightened sensitivity to light have also been reported. Muscle aches or back pain can occur in a minority of patients. Priapism a prolonged erection lasting more than four hours is a rare but serious occurrence that requires immediate attention. The medication may interact with certain antihypertensive drugs increasing the risk of hypotensive effects. Overall the frequency of adverse reactions tends to be low with most effects being mild and self limiting.